SLC22A2 Knockout HEK293 Cell Line
Cat.No.:
EDJ-KQ5799
Species:
Human
Cell Name:
HEK293
Gene:
SLC22A2
Gene ID:
6582
Size:
1×10⁶cells
SLC22A2 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDJ-KQ5799 |
|---|---|
| Product Name | SLC22A2 Knockout Cell Line(HEK 293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | |
| NCBI Gene ID | |
| Gene Synonyms | 45932 |
| Summary |
Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. This gene is one of three similar cation transporter genes located in a cluster on chromosome 6. The encoded protein contains twelve putative transmembrane domains and is a plasma integral membrane protein. It is found primarily in the kidney, where it may mediate the first step in cation reabsorption. [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
Research Publications
The organic cation transporters 1 and 2 mediate ethanolamine cellular efflux and control systemic phosphatidylethanolamine level.
IF=3.9
The Journal of biological chemistry
The organic cation transporters (OCTs) OCT1 on the basolateral membrane of enterocytes and hepatocytes and OCT2 on the basolateral membrane of proximal tubular cells are essential in regulating systemic micronutrient levels, while also safeguarding tissues by preventing the buildup of potentially harmful endogenous metabolites, drugs, and xenobiotics. In the present work, we integrated in vivo comparative metabolomics and lipidomics analyses of serum from WT and Oct1/2 mice with in vitro uptake measurements in HEK293 cells overexpressing OCT1 or OCT2, to identify and characterize novel endogenous substrates of OCT1/2. Among the significant metabolite changes, ethanolamine in the serum of Oct1/2 mice was approximately 70% lower than in WT mice. The ethanolamine influx K mediated by OCT1/2 ranged from 7.6 ± 3.7 mmol/L (mouse Oct2) to 13.4 ± 8.1 mmol/L (mouse Oct1). OCT1/2 did not transport ethanolamine at physiologically relevant extracellular concentrations (10-100 μmol/L), suggesting that OCTs do not play a role in the hepatic/renal uptake of ethanolamine. Conversely, the release of ethanolamine by cells pre-exposed to ethanolamine at the extracellular concentration of 50 μmol/l was significantly greater in the presence of OCTs. Finally, the serum of the Oct1/2 mice was characterized by a stark elevation across phosphatidylethanolamine and lysophosphatidylethanolamine species, but not in phosphatidylcholine and diacylglycerol species. Taken together, our in vitro and in vivo data indicate that mouse Oct1 and Oct2 are essential for facilitating the exit step of free ethanolamine vectorial transport and indirectly control systemic phosphatidylethanolamine level.
This KO model may be useful for:
- Investigating the role of SLC22A2 in organic cation transport and cellular efflux mechanisms
- Studying the regulation of systemic phosphatidylethanolamine levels via transporter-mediated choline/ethanolamine flux
- Exploring metabolic pathways linking transporter activity to phospholipid biosynthesis
- Evaluating drug-induced alterations in ethanolamine or phosphatidylethanolamine homeostasis
- Functional validation of SLC22A2 as a target in metabolic or hepatic disease models